000 -LEADER |
fixed length control field |
06109nam a22001697a 4500 |
005 - DATE AND TIME OF LATEST TRANSACTION |
control field |
20230121130737.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
fixed length control field |
230121b |||||||| |||| 00| 0 eng d |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
International Standard Book Number |
9781264711758 |
100 ## - MAIN ENTRY--PERSONAL NAME |
Personal name |
<a href="Fuster, Valentin, Ed...[et al.]">Fuster, Valentin, Ed...[et al.]</a> |
245 ## - TITLE STATEMENT |
Title |
Fuster and Hurst's The Heart |
250 ## - EDITION STATEMENT |
Edition statement |
15 |
260 ## - PUBLICATION, DISTRIBUTION, ETC. |
Place of publication, distribution, etc. |
New York |
Name of publisher, distributor, etc. |
Mc Graw Hill |
Date of publication, distribution, etc. |
2022 |
300 ## - PHYSICAL DESCRIPTION |
Extent |
2407 p. |
500 ## - GENERAL NOTE |
General note |
Table of Contents<br/>Section I: Introduction<br/>Chapter 1: The Global Burden of Cardiovascular Diseases<br/>Chapter 2: Clinical Cardiovascular Examination<br/>Chapter 3: Cardiovascular Imaging<br/>Chapter 4: Genomics And Epigenomics of Heart Diseases<br/>Section II: Risk Factors for Cardiovascular Disease<br/>Chapter 5: Epidemiology, Pathophysiology, and Treatment of Hypertension<br/>Chapter 6: Cardiometabolic Disease: Insulin Resistance, Obesity, and the Metabolic Syndrome<br/>Chapter 7: Diabetes and Cardiovascular Disease<br/>Chapter 8: Tobacco-Related Cardiovascular Disease<br/>Chapter 9: Air Pollution and Cardiovascular Disease<br/>Chapter 10: Hypercholesterolemia, Hyperlipoprotein(a), Hypertriglyceridemia, and Low HDL<br/>Chapter 11: Psychological Factors in Cardiovascular Health and Disease<br/>Chapter 12: Sedentary Lifestyle and Role of Exercise in Cardiovascular Diseases<br/>Chapter 13: Nutrition, Diet, and Alcohol in Health and Cardiovascular Disease<br/>Chapter 14: Inflammation and Atherosclerosis<br/>Chapter 15: Location and Level of Care, Education, Availability of Medicines, and Cardiovascular Mortality<br/>Section III: Atherosclerosis and Coronary Heart Disease<br/>Chapter 16: Pathological Basis of Atherosclerotic Coronary Artery Disease<br/>Chapter 17: Pathogenesis of Coronary Thrombosis and Myocardial Infarction<br/>Chapter 18: ST-Elevation Myocardial Infarction<br/>Chapter 19: Evaluation and Management of Non–ST-Segment Elevation Acute Coronary Syndromes<br/>Chapter 20: Mimickers of Atherosclerotic Myocardial Infarction: SCAD, Coronary Vasospasm, Myocarditis, and Takotsubo Syndrome<br/>Chapter 21: Chronic Coronary Syndromes<br/>Chapter 22: Cardiac Rehabilitation: Current Practice and Future Directions<br/>Section IV: Diseases of the Great Vessels and Peripheral Vessels<br/>Chapter 23: Diseases of the Aorta<br/>Chapter 24: Carotid Artery Disease<br/>Chapter 25: Cerebrovascular Disease<br/>Chapter 26: Diagnosis and Management of Diseases of the Peripheral Arteries<br/>Section V: Valvular Heart Disease<br/>Chapter 27: Acute Rheumatic Fever<br/>Chapter 28: Aortic Stenosis<br/>Chapter 29: Aortic Regurgitation, Mixed Valvular Heart Disease, and Heart Valve Prostheses<br/>Chapter 30: Mitral Regurgitation<br/>Chapter 31: Acquired Tricuspid Valve Diseases<br/>Chapter 32: Mitral Stenosis<br/>Chapter 33: Infective Endocarditis<br/>Section VI: Rhythm and Conduction Abnormalities<br/>Chapter 34: Electrophysiologic Anatomy, Mechanisms of Arrhythmias and Conduction Disturbances, and Genetics<br/>Chapter 35: Supraventricular Tachycardia: Atrial Tachycardia, Atrioventricular Nodal Reentry, and Wolff-Parkinson-White Syndrome<br/>Chapter 36: Atrial Fibrillation and Atrial Flutter<br/>Chapter 37: Ventricular Arrhythmias and Sudden Cardiac Death<br/>Chapter 38: Conduction System Disturbances and Bradyarrhythmias<br/>Chapter 39: Diagnosis and Management of Syncope<br/>Section VII: Heart Failure<br/>Chapter 40: Classification of Cardiomyopathies<br/>Chapter 41: Dilated Cardiomyopathy<br/>Chapter 42: Hypertrophic Cardiomyopathy<br/>Chapter 43: Cardiac Amyloidosis<br/>Chapter 44: Restrictive Heart Diseases<br/>Chapter 45: Left Ventricular Noncompaction<br/>Chapter 46: Myocarditis<br/>Chapter 47: Obstructive and Nonobstructive Coronary Disease in Heart Failure<br/>Chapter 48: Diagnosis and Management of Chronic Heart Failure<br/>Chapter 49: Diagnosis and Management of Heart Failure with Preserved Ejection Fraction<br/>Chapter 50: Evaluation and Management of Acute Heart Failure – Updated October 2022<br/>Chapter 51: Peripartum Cardiomyopathy<br/>Chapter 52: Mechanical Circulatory Support and Heart Transplantation in Severe Heart Failure<br/>Section VIII: Diseases of the Pericardium<br/>Chapter 53: Acute Pericarditis<br/>Chapter 54: Percardial Effusion and Tamponade<br/>Chapter 55: Constrictive Pericarditis<br/>Section IX: Cardiopulmonary Disease<br/>Chapter 56: Diagnosis and Management of Diseases of the Peripheral Venous System<br/>Chapter 57: Pulmonary Hypertension<br/>Chapter 58: Pulmonary Embolism<br/>Chapter 59: Cor Pulmonale: The Heart in Structural Lung Disease<br/>Chapter 60: Sleep-Disordered Breathing<br/>Section X: Critical Cardiovascular Care<br/>Chapter 61: Evolution of Cardiac Critical Care<br/>Chapter 62: Circulatory and Cardiogenic Shock<br/>Chapter 63: Sudden Cardiac Death and Resuscitation<br/>Chapter 64: Postoperative and Postprocedural Care in the Cardiac Intensive Care Unit<br/>Section XI: Adult Congenital Heart Disease<br/>Chapter 65: Anatomical and Physiological Classification of Adult Congenital Heart Disease<br/>Chapter 66: Shunt Lesions<br/>Chapter 67: Right-Sided Lesions<br/>Chapter 68: Left Heart Obstructive Lesions<br/>Chapter 69: Single Ventricle Post Fontan Palliation: Tricuspid Atresia, Pulmonary Atresia, and Hypoplastic Left Heart Syndrome<br/>Chapter 70: Complex Cyanotic Congenital Heart Disease: The “Mixing” Lesions<br/>Chapter 71: Psychosocial Profiles in Adult Congenital Heart Disease and Transition to Adulthood<br/>Section XII: Special Populations and Topics in Cardiovascular Disease<br/>Chapter 72: Perioperative Evaluation for Noncardiac Surgery<br/>Chapter 73: Anesthesia and the Patient with Cardiovascular Disease<br/>Chapter 74: Cardiovascular Disease in Patients with Cancer and Cardiovascular Complications of Cancer Therapies<br/>Chapter 75: Heart Disease in Chronic Kidney Disease<br/>Chapter 76: Rheumatologic Disease and the Cardiovascular System<br/>Chapter 77: Cardiovascular Disease in Patients with HIV<br/>Chapter 78: Heart Disease in Pregnancy<br/>Chapter 79: Traumatic Heart Disease<br/>Chapter 80: Women and Ischemic Heart Disease<br/>Chapter 81: Race, Ethnicity, Disparities, Diversity, and Heart Disease<br/>Chapter 82: Cardiovascular Disease and Ageing: Cellular and Molecular Mechanisms<br/>Chapter 83: Artificial Intelligence and Cardiovascular Care<br/>Chapter 84: Cardiovascular Manifestations of COVID-19 |
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Cardiology; Heart diseases |
942 ## - ADDED ENTRY ELEMENTS (KOHA) |
Source of classification or shelving scheme |
|
Koha item type |
Books |